| 0 |
WT1 GENE MUTATION |
7 |
0.7778 |
| 1 |
PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION |
3 |
0.5000 |
| 2 |
BILIARY TRACT INFECTION FUNGAL |
4 |
0.4444 |
| 3 |
METAMYELOCYTE PERCENTAGE |
2 |
0.4000 |
| 4 |
GENE MUTATION IDENTIFICATION TEST NEGATIVE |
4 |
0.3077 |
| 5 |
TUMOUR CELL MOBILISATION |
3 |
0.3000 |
| 6 |
FLT3 GENE MUTATION |
4 |
0.2667 |
| 7 |
METAMYELOCYTE COUNT |
2 |
0.2500 |
| 8 |
LEFT ATRIAL HYPERTROPHY |
11 |
0.2200 |
| 9 |
GRAFT VERSUS HOST DISEASE ORAL |
9 |
0.1406 |
| 10 |
DIFFERENTIATION SYNDROME |
103 |
0.1403 |
| 11 |
MORGANELLA TEST POSITIVE |
3 |
0.1250 |
| 12 |
MONOCYTE PERCENTAGE ABNORMAL |
2 |
0.0909 |
| 13 |
ADENOVIRAL ENCEPHALITIS |
1 |
0.0909 |
| 14 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
180 |
0.0838 |
| 15 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
13 |
0.0756 |
| 16 |
LEPTOTRICHIA INFECTION |
3 |
0.0667 |
| 17 |
PNEUMONIA ADENOVIRAL |
13 |
0.0657 |
| 18 |
SEPTAL PANNICULITIS |
5 |
0.0625 |
| 19 |
BLAST CELL COUNT INCREASED |
62 |
0.0592 |
| 20 |
ELECTROCARDIOGRAM PR SHORTENED |
12 |
0.0571 |
| 21 |
ADENOVIRAL HEPATITIS |
13 |
0.0553 |
| 22 |
BASOPHIL PERCENTAGE DECREASED |
2 |
0.0541 |
| 23 |
ACUTE MACULAR OUTER RETINOPATHY |
1 |
0.0526 |
| 24 |
MYELOBLAST COUNT INCREASED |
4 |
0.0519 |
| 25 |
ASPIRATION BONE MARROW ABNORMAL |
7 |
0.0519 |
| 26 |
ERYTHROBLAST COUNT INCREASED |
3 |
0.0500 |
| 27 |
RADIATION FIBROSIS - LUNG |
3 |
0.0484 |
| 28 |
EUTHYROID SICK SYNDROME |
4 |
0.0471 |
| 29 |
CORYNEBACTERIUM BACTERAEMIA |
4 |
0.0471 |
| 30 |
CAPNOCYTOPHAGA INFECTION |
4 |
0.0426 |
| 31 |
BLAST CELL COUNT DECREASED |
3 |
0.0411 |
| 32 |
NEUTROPHIL PERCENTAGE ABNORMAL |
2 |
0.0400 |
| 33 |
PRE-ENGRAFTMENT IMMUNE REACTION |
3 |
0.0375 |
| 34 |
BIFIDOBACTERIUM INFECTION |
1 |
0.0370 |
| 35 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
9 |
0.0353 |
| 36 |
ADENOVIRAL CONJUNCTIVITIS |
1 |
0.0345 |
| 37 |
GLOBULIN ABNORMAL |
2 |
0.0345 |
| 38 |
DELAYED HAEMOLYTIC TRANSFUSION REACTION |
2 |
0.0339 |
| 39 |
MEAN CELL HAEMOGLOBIN CONCENTRATION |
2 |
0.0328 |
| 40 |
ACUTE GRAFT VERSUS HOST DISEASE ORAL |
1 |
0.0323 |
| 41 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
12 |
0.0305 |
| 42 |
IMMUNOSUPPRESSANT DRUG LEVEL ABNORMAL |
2 |
0.0303 |
| 43 |
LYMPHOCYTE PERCENTAGE ABNORMAL |
2 |
0.0290 |
| 44 |
LEUKAEMIC INFILTRATION |
4 |
0.0286 |
| 45 |
NONINFECTIVE SIALOADENITIS |
4 |
0.0252 |
| 46 |
GRAFT VERSUS HOST DISEASE IN LIVER |
18 |
0.0251 |
| 47 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
6 |
0.0245 |
| 48 |
DISSEMINATED ASPERGILLOSIS |
11 |
0.0233 |
| 49 |
MYELOCYTOSIS |
2 |
0.0233 |
| 50 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
4 |
0.0231 |
| 51 |
BLAST CELLS PRESENT |
11 |
0.0229 |
| 52 |
MINIMAL RESIDUAL DISEASE |
11 |
0.0228 |
| 53 |
TUMOUR ASSOCIATED FEVER |
9 |
0.0220 |
| 54 |
ACUTE MYELOID LEUKAEMIA |
342 |
0.0219 |
| 55 |
TRANSPLANTATION COMPLICATION |
9 |
0.0214 |
| 56 |
GRAFT VERSUS HOST DISEASE IN SKIN |
47 |
0.0213 |
| 57 |
ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA |
1 |
0.0208 |
| 58 |
BK POLYOMAVIRUS TEST POSITIVE |
2 |
0.0208 |
| 59 |
BLOOD ERYTHROPOIETIN INCREASED |
2 |
0.0202 |
| 60 |
IMAGING PROCEDURE ABNORMAL |
2 |
0.0200 |
| 61 |
BLOOD IMMUNOGLOBULIN M ABNORMAL |
2 |
0.0194 |
| 62 |
OESOPHAGEAL INTRAMURAL HAEMATOMA |
2 |
0.0190 |
| 63 |
CHLOROMA |
8 |
0.0190 |
| 64 |
BACILLUS BACTERAEMIA |
2 |
0.0183 |
| 65 |
AUTOIMMUNE ANAEMIA |
1 |
0.0182 |
| 66 |
INTERSTITIAL LUNG ABNORMALITY |
2 |
0.0175 |
| 67 |
ENGRAFT FAILURE |
5 |
0.0174 |
| 68 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
4 |
0.0172 |
| 69 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
36 |
0.0169 |
| 70 |
CYSTITIS VIRAL |
6 |
0.0157 |
| 71 |
CHRONIC GRAFT VERSUS HOST DISEASE IN EYE |
3 |
0.0148 |
| 72 |
MONOCYTOSIS |
9 |
0.0145 |
| 73 |
GEOTRICHUM INFECTION |
3 |
0.0142 |
| 74 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
33 |
0.0142 |
| 75 |
ENTEROCOCCAL BACTERAEMIA |
15 |
0.0142 |
| 76 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
5 |
0.0137 |
| 77 |
DILATATION INTRAHEPATIC DUCT ACQUIRED |
4 |
0.0137 |
| 78 |
CYTOPENIA |
167 |
0.0136 |
| 79 |
ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0133 |
| 80 |
GRAFT VERSUS HOST DISEASE IN EYE |
3 |
0.0130 |
| 81 |
LEUKAEMIA CUTIS |
2 |
0.0130 |
| 82 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
12 |
0.0130 |
| 83 |
CONGENITAL APLASIA |
4 |
0.0129 |
| 84 |
ALLOGENIC STEM CELL TRANSPLANTATION |
2 |
0.0127 |
| 85 |
GRAFT VERSUS HOST DISEASE IN LUNG |
6 |
0.0126 |
| 86 |
MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL |
2 |
0.0124 |
| 87 |
BACTERIAL TRACHEITIS |
1 |
0.0123 |
| 88 |
BLOOD IMMUNOGLOBULIN G ABNORMAL |
2 |
0.0120 |
| 89 |
ENGRAFTMENT SYNDROME |
7 |
0.0118 |
| 90 |
ANTITHROMBIN III DEFICIENCY |
1 |
0.0112 |
| 91 |
DRUG RESISTANCE MUTATION |
2 |
0.0112 |
| 92 |
ACUTE MONOCYTIC LEUKAEMIA |
2 |
0.0110 |
| 93 |
GRAFT VERSUS HOST DISEASE |
79 |
0.0110 |
| 94 |
METASTASES TO NERVOUS SYSTEM |
2 |
0.0109 |
| 95 |
MUSCULOSKELETAL TOXICITY |
2 |
0.0108 |
| 96 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
3 |
0.0106 |
| 97 |
CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE |
2 |
0.0105 |
| 98 |
RED CELL DISTRIBUTION WIDTH ABNORMAL |
2 |
0.0105 |
| 99 |
BIOPSY BREAST ABNORMAL |
1 |
0.0105 |
| 100 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
3 |
0.0101 |
| 101 |
NEUTROPHILIC DERMATOSIS |
4 |
0.0101 |
| 102 |
PNEUMONIA FUNGAL |
39 |
0.0099 |
| 103 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
27 |
0.0098 |
| 104 |
THROMBOPHLEBITIS SEPTIC |
2 |
0.0098 |
| 105 |
ASPERGILLUS TEST POSITIVE |
3 |
0.0097 |
| 106 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
7 |
0.0097 |
| 107 |
SALMONELLA BACTERAEMIA |
2 |
0.0097 |
| 108 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
2 |
0.0096 |
| 109 |
PERICARDITIS CONSTRICTIVE |
4 |
0.0095 |
| 110 |
FEMALE REPRODUCTIVE TRACT DISORDER |
2 |
0.0092 |
| 111 |
SEROSITIS |
5 |
0.0090 |
| 112 |
MONOCYTE COUNT ABNORMAL |
2 |
0.0090 |
| 113 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
13 |
0.0090 |
| 114 |
MYOPERICARDITIS |
7 |
0.0090 |
| 115 |
METAPNEUMOVIRUS INFECTION |
7 |
0.0089 |
| 116 |
MYELOSUPPRESSION |
312 |
0.0087 |
| 117 |
HAIRY CELL LEUKAEMIA |
2 |
0.0086 |
| 118 |
MUCOSAL DISORDER |
8 |
0.0080 |
| 119 |
REMISSION NOT ACHIEVED |
5 |
0.0080 |
| 120 |
KLEBSIELLA SEPSIS |
9 |
0.0080 |
| 121 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
11 |
0.0078 |
| 122 |
LEUKAEMIA RECURRENT |
13 |
0.0077 |
| 123 |
CHRONIC GRAFT VERSUS HOST DISEASE |
27 |
0.0075 |
| 124 |
ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY |
1 |
0.0074 |
| 125 |
ATOPY |
2 |
0.0072 |
| 126 |
ANAEMIA OF MALIGNANT DISEASE |
2 |
0.0071 |
| 127 |
CEREBRAL FUNGAL INFECTION |
2 |
0.0071 |
| 128 |
CARDIORENAL SYNDROME |
4 |
0.0070 |
| 129 |
HYPERFERRITINAEMIA |
3 |
0.0070 |
| 130 |
MOUTH BREATHING |
3 |
0.0069 |
| 131 |
IDIOPATHIC PNEUMONIA SYNDROME |
2 |
0.0067 |
| 132 |
BLOOD BETA-D-GLUCAN INCREASED |
2 |
0.0065 |
| 133 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
6 |
0.0065 |
| 134 |
LUNG OPACITY |
17 |
0.0064 |
| 135 |
URINARY TRACT INFECTION ENTEROCOCCAL |
6 |
0.0064 |
| 136 |
CARBON DIOXIDE ABNORMAL |
2 |
0.0064 |
| 137 |
PULMONARY VASCULAR DISORDER |
3 |
0.0064 |
| 138 |
ENTEROCOCCAL SEPSIS |
5 |
0.0062 |
| 139 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
4 |
0.0061 |
| 140 |
BLAST CELL CRISIS |
2 |
0.0060 |
| 141 |
MYELOID LEUKAEMIA |
3 |
0.0060 |
| 142 |
COMPLICATIONS OF TRANSPLANT SURGERY |
3 |
0.0059 |
| 143 |
ADENOVIRUS INFECTION |
17 |
0.0059 |
| 144 |
PULMONARY VENO-OCCLUSIVE DISEASE |
4 |
0.0057 |
| 145 |
ACUTE GRAFT VERSUS HOST DISEASE |
26 |
0.0057 |
| 146 |
SCEDOSPORIUM INFECTION |
4 |
0.0057 |
| 147 |
HYPERLEUKOCYTOSIS |
5 |
0.0056 |
| 148 |
IRON OVERLOAD |
6 |
0.0056 |
| 149 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
2 |
0.0055 |
| 150 |
PITYRIASIS ROSEA |
2 |
0.0054 |
| 151 |
ATYPICAL PNEUMONIA |
16 |
0.0053 |
| 152 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
7 |
0.0053 |
| 153 |
CREATINE KINASE INCREASED |
4 |
0.0052 |
| 154 |
AMYLASE INCREASED |
19 |
0.0051 |
| 155 |
FEBRILE INFECTION |
6 |
0.0051 |
| 156 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
11 |
0.0050 |
| 157 |
BONE ABSCESS |
2 |
0.0049 |
| 158 |
ACOUSTIC NEUROMA |
2 |
0.0049 |
| 159 |
PERIORBITAL HAEMATOMA |
4 |
0.0049 |
| 160 |
CANDIDA TEST POSITIVE |
2 |
0.0048 |
| 161 |
GENE MUTATION IDENTIFICATION TEST POSITIVE |
2 |
0.0048 |
| 162 |
BACTERAEMIA |
56 |
0.0047 |
| 163 |
BRONCHOPULMONARY ASPERGILLOSIS |
36 |
0.0046 |
| 164 |
APLASIA |
9 |
0.0046 |
| 165 |
OBLITERATIVE BRONCHIOLITIS |
6 |
0.0046 |
| 166 |
FUSARIUM INFECTION |
3 |
0.0043 |
| 167 |
ESCHERICHIA BACTERAEMIA |
10 |
0.0042 |
| 168 |
WOLFF-PARKINSON-WHITE SYNDROME |
2 |
0.0042 |
| 169 |
MEAN CELL VOLUME ABNORMAL |
2 |
0.0042 |
| 170 |
ABSENCE OF IMMEDIATE TREATMENT RESPONSE |
1 |
0.0042 |
| 171 |
VIRAL HAEMORRHAGIC CYSTITIS |
3 |
0.0042 |
| 172 |
KLEBSIELLA BACTERAEMIA |
4 |
0.0042 |
| 173 |
ESCHERICHIA TEST POSITIVE |
5 |
0.0042 |
| 174 |
BRONCHIAL WALL THICKENING |
3 |
0.0042 |
| 175 |
PHILADELPHIA CHROMOSOME POSITIVE |
3 |
0.0041 |
| 176 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
18 |
0.0041 |
| 177 |
CARDIAC DYSFUNCTION |
15 |
0.0040 |
| 178 |
EOSINOPHIL COUNT ABNORMAL |
3 |
0.0040 |
| 179 |
ELECTROCARDIOGRAM QT INTERVAL ABNORMAL |
2 |
0.0040 |
| 180 |
ANORECTAL INFECTION |
1 |
0.0040 |
| 181 |
ANAL INFECTION |
1 |
0.0039 |
| 182 |
PLATELET TRANSFUSION |
5 |
0.0039 |
| 183 |
NEUTROPENIC COLITIS |
8 |
0.0039 |
| 184 |
FEBRILE NEUTROPENIA |
252 |
0.0038 |
| 185 |
BLOOD DISORDER |
30 |
0.0037 |
| 186 |
PERIORBITAL CELLULITIS |
2 |
0.0037 |
| 187 |
STENOTROPHOMONAS INFECTION |
5 |
0.0037 |
| 188 |
GASTROENTERITIS ESCHERICHIA COLI |
2 |
0.0037 |
| 189 |
FUNGAL SEPSIS |
3 |
0.0036 |
| 190 |
SEPTIC EMBOLUS |
3 |
0.0036 |
| 191 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
57 |
0.0036 |
| 192 |
MYOCARDIAL NECROSIS MARKER INCREASED |
6 |
0.0036 |
| 193 |
MYOCARDIAL INJURY |
4 |
0.0036 |
| 194 |
TUMOUR LYSIS SYNDROME |
31 |
0.0035 |
| 195 |
INTENSIVE CARE |
5 |
0.0035 |
| 196 |
INFECTION REACTIVATION |
4 |
0.0035 |
| 197 |
NEUTROPHIL COUNT DECREASED |
141 |
0.0035 |
| 198 |
HEPATIC FUNCTION ABNORMAL |
128 |
0.0034 |
| 199 |
PSEUDOMONAL SEPSIS |
6 |
0.0034 |
| 200 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
3 |
0.0034 |
| 201 |
ALVEOLAR PROTEINOSIS |
2 |
0.0034 |
| 202 |
CAMPYLOBACTER GASTROENTERITIS |
2 |
0.0034 |
| 203 |
FEBRILE BONE MARROW APLASIA |
14 |
0.0033 |
| 204 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
5 |
0.0033 |
| 205 |
PSOAS ABSCESS |
2 |
0.0032 |
| 206 |
ELECTROCARDIOGRAM QT PROLONGED |
114 |
0.0032 |
| 207 |
NEUTROPENIC INFECTION |
3 |
0.0031 |
| 208 |
ASPERGILLOMA |
1 |
0.0031 |
| 209 |
ENTEROCOCCAL INFECTION |
15 |
0.0031 |
| 210 |
PNEUMONIA CYTOMEGALOVIRAL |
6 |
0.0031 |
| 211 |
ACUTE LEFT VENTRICULAR FAILURE |
2 |
0.0030 |
| 212 |
ORGAN FAILURE |
12 |
0.0030 |
| 213 |
BK VIRUS INFECTION |
10 |
0.0030 |
| 214 |
NON-CARDIOGENIC PULMONARY OEDEMA |
3 |
0.0028 |
| 215 |
HEPATIC CYTOLYSIS |
36 |
0.0028 |
| 216 |
CYTOMEGALOVIRUS TEST POSITIVE |
5 |
0.0028 |
| 217 |
PLATELET COUNT DECREASED |
298 |
0.0028 |
| 218 |
KLEBSIELLA INFECTION |
14 |
0.0028 |
| 219 |
PANCREATIC ENZYMES INCREASED |
4 |
0.0027 |
| 220 |
SOFT TISSUE INFECTION |
5 |
0.0027 |
| 221 |
LYMPH NODE TUBERCULOSIS |
2 |
0.0027 |
| 222 |
SERRATIA INFECTION |
2 |
0.0027 |
| 223 |
FULL BLOOD COUNT DECREASED |
54 |
0.0027 |
| 224 |
PNEUMONIA PSEUDOMONAL |
4 |
0.0026 |
| 225 |
OSTEOCHONDROSIS |
3 |
0.0026 |
| 226 |
ERYTHEMA NODOSUM |
9 |
0.0026 |
| 227 |
WHITE BLOOD CELL COUNT ABNORMAL |
16 |
0.0025 |
| 228 |
HAEMATOMA MUSCLE |
3 |
0.0025 |
| 229 |
DYSPLASIA |
3 |
0.0025 |
| 230 |
RENAL TUBULAR INJURY |
3 |
0.0025 |
| 231 |
SECONDARY IMMUNODEFICIENCY |
3 |
0.0025 |
| 232 |
STARVATION |
2 |
0.0024 |
| 233 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
18 |
0.0024 |
| 234 |
LUNG INFILTRATION |
21 |
0.0024 |
| 235 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
2 |
0.0024 |
| 236 |
STAPHYLOCOCCUS TEST POSITIVE |
5 |
0.0024 |
| 237 |
ALANINE AMINOTRANSFERASE ABNORMAL |
5 |
0.0024 |
| 238 |
BONE SCAN ABNORMAL |
1 |
0.0024 |
| 239 |
NOCARDIOSIS |
6 |
0.0023 |
| 240 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 241 |
BLOOD CREATININE ABNORMAL |
8 |
0.0023 |
| 242 |
TRANSFUSION REACTION |
2 |
0.0023 |
| 243 |
PANCYTOPENIA |
126 |
0.0023 |
| 244 |
PSEUDOMEMBRANOUS COLITIS |
5 |
0.0022 |
| 245 |
CYSTITIS HAEMORRHAGIC |
9 |
0.0022 |
| 246 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
2 |
0.0022 |
| 247 |
BLOOD CREATINE PHOSPHOKINASE ABNORMAL |
1 |
0.0022 |
| 248 |
PNEUMOMEDIASTINUM |
4 |
0.0022 |
| 249 |
HEPATOTOXICITY |
49 |
0.0022 |
| 250 |
BONE INFARCTION |
1 |
0.0022 |
| 251 |
ENTEROCOLITIS INFECTIOUS |
2 |
0.0022 |
| 252 |
LIVER ABSCESS |
7 |
0.0022 |
| 253 |
BACTERIAL SEPSIS |
7 |
0.0021 |
| 254 |
BIOPSY BONE MARROW |
1 |
0.0021 |
| 255 |
BLOOD UREA ABNORMAL |
2 |
0.0021 |
| 256 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
61 |
0.0021 |
| 257 |
CATHETER SITE INFECTION |
8 |
0.0021 |
| 258 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
7 |
0.0021 |
| 259 |
TRANSPLANT |
5 |
0.0021 |
| 260 |
INVESTIGATION ABNORMAL |
3 |
0.0021 |
| 261 |
HEPATIC MASS |
4 |
0.0021 |
| 262 |
HAEMATOLOGICAL INFECTION |
5 |
0.0020 |
| 263 |
DEVICE RELATED THROMBOSIS |
2 |
0.0020 |
| 264 |
CHOLANGIOCARCINOMA |
3 |
0.0020 |
| 265 |
GASTRITIS HAEMORRHAGIC |
3 |
0.0020 |
| 266 |
SYSTEMIC CANDIDA |
5 |
0.0020 |
| 267 |
BONE MARROW FAILURE |
40 |
0.0020 |
| 268 |
PHYSICAL DECONDITIONING |
5 |
0.0019 |
| 269 |
FUNGAEMIA |
3 |
0.0019 |
| 270 |
ENTEROCOLITIS |
11 |
0.0019 |
| 271 |
URETEROLITHIASIS |
2 |
0.0019 |
| 272 |
POLYOMAVIRUS VIRAEMIA |
2 |
0.0019 |
| 273 |
HYPERTENSIVE NEPHROPATHY |
2 |
0.0019 |
| 274 |
STREPTOCOCCAL BACTERAEMIA |
2 |
0.0018 |
| 275 |
CEREBELLAR INFARCTION |
3 |
0.0018 |
| 276 |
CYTOGENETIC ABNORMALITY |
2 |
0.0018 |
| 277 |
SUSPECTED OFF LABEL USE |
8 |
0.0018 |
| 278 |
SEPTIC SHOCK |
77 |
0.0018 |
| 279 |
NEUTROPHIL COUNT ABNORMAL |
5 |
0.0018 |
| 280 |
THROMBOTIC MICROANGIOPATHY |
17 |
0.0017 |
| 281 |
MYCOBACTERIAL INFECTION |
3 |
0.0017 |
| 282 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
48 |
0.0017 |
| 283 |
HERPES SIMPLEX |
11 |
0.0017 |
| 284 |
HAEMATOTOXICITY |
16 |
0.0017 |
| 285 |
CARDIOTOXICITY |
15 |
0.0017 |
| 286 |
PNEUMONIA INFLUENZAL |
2 |
0.0017 |
| 287 |
ASPERGILLUS INFECTION |
11 |
0.0017 |
| 288 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
2 |
0.0017 |
| 289 |
BONE MARROW DISORDER |
5 |
0.0017 |
| 290 |
HYPERPYREXIA |
7 |
0.0017 |
| 291 |
PANNICULITIS |
4 |
0.0017 |
| 292 |
CLOSTRIDIUM COLITIS |
2 |
0.0016 |
| 293 |
FEBRILE CONVULSION |
2 |
0.0016 |
| 294 |
DISSEMINATED INTRAVASCULAR COAGULATION |
23 |
0.0016 |
| 295 |
LARGE INTESTINE INFECTION |
2 |
0.0016 |
| 296 |
HAEMATOCRIT ABNORMAL |
2 |
0.0016 |
| 297 |
LIVER DISORDER |
72 |
0.0016 |
| 298 |
VENOOCCLUSIVE LIVER DISEASE |
8 |
0.0016 |
| 299 |
INTRA-ABDOMINAL HAEMATOMA |
2 |
0.0016 |
| 300 |
LUPUS NEPHRITIS |
3 |
0.0016 |
| 301 |
STEM CELL TRANSPLANT |
4 |
0.0016 |
| 302 |
VENOOCCLUSIVE DISEASE |
4 |
0.0016 |
| 303 |
BACILLUS INFECTION |
1 |
0.0016 |
| 304 |
BRAIN ABSCESS |
4 |
0.0016 |
| 305 |
HEPATIC INFECTION |
2 |
0.0016 |
| 306 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 307 |
PORTAL VEIN THROMBOSIS |
5 |
0.0015 |
| 308 |
ABDOMINAL WALL ABSCESS |
1 |
0.0015 |
| 309 |
UNDERDOSE |
112 |
0.0015 |
| 310 |
DISEASE COMPLICATION |
7 |
0.0015 |
| 311 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
0.0015 |
| 312 |
DEVICE RELATED SEPSIS |
3 |
0.0015 |
| 313 |
TRANSAMINASES INCREASED |
33 |
0.0015 |
| 314 |
BLOOD PHOSPHORUS INCREASED |
4 |
0.0015 |
| 315 |
ESCHERICHIA INFECTION |
12 |
0.0015 |
| 316 |
CAPILLARY LEAK SYNDROME |
3 |
0.0014 |
| 317 |
BRAIN CANCER METASTATIC |
1 |
0.0014 |
| 318 |
LIVEDO RETICULARIS |
3 |
0.0014 |
| 319 |
LIPASE INCREASED |
11 |
0.0014 |
| 320 |
PULMONARY ALVEOLAR HAEMORRHAGE |
8 |
0.0014 |
| 321 |
URINARY BLADDER HAEMORRHAGE |
3 |
0.0014 |
| 322 |
ATYPICAL MYCOBACTERIAL INFECTION |
2 |
0.0014 |
| 323 |
GLOMERULAR FILTRATION RATE ABNORMAL |
2 |
0.0014 |
| 324 |
SUBDURAL HAEMATOMA |
20 |
0.0014 |
| 325 |
HYPERPHOSPHATAEMIA |
3 |
0.0014 |
| 326 |
EXOPHTHALMOS |
3 |
0.0014 |
| 327 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
14 |
0.0014 |
| 328 |
ESCHERICHIA SEPSIS |
4 |
0.0014 |
| 329 |
BLOOD FOLATE DECREASED |
1 |
0.0014 |
| 330 |
BACTERIAL DISEASE CARRIER |
1 |
0.0014 |
| 331 |
THROMBOCYTOPENIA |
152 |
0.0014 |
| 332 |
ENTEROCOLITIS HAEMORRHAGIC |
2 |
0.0014 |
| 333 |
PRODUCT USE ISSUE |
254 |
0.0014 |
| 334 |
GASTROINTESTINAL WALL THICKENING |
2 |
0.0013 |
| 335 |
STEROID DIABETES |
2 |
0.0013 |
| 336 |
SERUM FERRITIN INCREASED |
7 |
0.0013 |
| 337 |
MYELOFIBROSIS |
4 |
0.0013 |
| 338 |
FIBROSIS |
4 |
0.0013 |
| 339 |
BACTERIAL INFECTION |
24 |
0.0013 |
| 340 |
PNEUMONIA LEGIONELLA |
2 |
0.0012 |
| 341 |
GUILLAIN-BARRE SYNDROME |
6 |
0.0012 |
| 342 |
FUNGAL SKIN INFECTION |
5 |
0.0012 |
| 343 |
MOUTH HAEMORRHAGE |
9 |
0.0012 |
| 344 |
ANAL ULCER |
1 |
0.0012 |
| 345 |
TRANSPLANT FAILURE |
3 |
0.0012 |
| 346 |
EJECTION FRACTION DECREASED |
19 |
0.0012 |
| 347 |
MYOCARDITIS |
14 |
0.0012 |
| 348 |
HYPERVOLAEMIA |
6 |
0.0012 |
| 349 |
TROPONIN I INCREASED |
2 |
0.0012 |
| 350 |
SEPSIS |
133 |
0.0012 |
| 351 |
ENTEROBACTER INFECTION |
2 |
0.0012 |
| 352 |
PLATELET DISORDER |
3 |
0.0012 |
| 353 |
SKIN WOUND |
2 |
0.0012 |
| 354 |
APTYALISM |
1 |
0.0012 |
| 355 |
HEPATOSPLENOMEGALY |
3 |
0.0012 |
| 356 |
LEUKAEMIA |
11 |
0.0012 |
| 357 |
LEUKOCYTOSIS |
21 |
0.0012 |
| 358 |
PERIORBITAL OEDEMA |
6 |
0.0012 |
| 359 |
MUCORMYCOSIS |
3 |
0.0012 |
| 360 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
11 |
0.0012 |
| 361 |
WHITE BLOOD CELL COUNT INCREASED |
44 |
0.0011 |
| 362 |
MELAENA |
25 |
0.0011 |
| 363 |
GASTROINTESTINAL OEDEMA |
2 |
0.0011 |
| 364 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
2 |
0.0011 |
| 365 |
PULMONARY TOXICITY |
8 |
0.0011 |
| 366 |
HISTOPLASMOSIS |
2 |
0.0011 |
| 367 |
WHITE BLOOD CELL COUNT DECREASED |
122 |
0.0011 |
| 368 |
JUGULAR VEIN THROMBOSIS |
2 |
0.0011 |
| 369 |
NEUTROPENIC SEPSIS |
8 |
0.0011 |
| 370 |
INFECTION |
161 |
0.0011 |
| 371 |
PYODERMA GANGRENOSUM |
4 |
0.0011 |
| 372 |
LARGE INTESTINAL ULCER |
3 |
0.0011 |
| 373 |
ANEURYSM RUPTURED |
1 |
0.0011 |
| 374 |
PNEUMONIA KLEBSIELLA |
2 |
0.0011 |
| 375 |
BIOPSY |
1 |
0.0011 |
| 376 |
LUNG CONSOLIDATION |
3 |
0.0011 |
| 377 |
LIVER FUNCTION TEST INCREASED |
23 |
0.0011 |
| 378 |
ENDOTRACHEAL INTUBATION |
3 |
0.0011 |
| 379 |
HYPERTENSIVE HEART DISEASE |
2 |
0.0011 |
| 380 |
NEUTROPENIA |
144 |
0.0011 |
| 381 |
HUMAN HERPESVIRUS 6 INFECTION |
2 |
0.0011 |
| 382 |
CHEMOTHERAPY |
4 |
0.0011 |
| 383 |
BONE MARROW TRANSPLANT |
2 |
0.0011 |
| 384 |
EARLY SATIETY |
2 |
0.0010 |
| 385 |
LYMPHOPROLIFERATIVE DISORDER |
3 |
0.0010 |
| 386 |
TOOTH DISCOLOURATION |
3 |
0.0010 |
| 387 |
HYPERTRANSAMINASAEMIA |
7 |
0.0010 |
| 388 |
EMPYEMA |
2 |
0.0010 |
| 389 |
HEPATIC ENZYME ABNORMAL |
5 |
0.0010 |
| 390 |
PATHOGEN RESISTANCE |
9 |
0.0010 |
| 391 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
6 |
0.0010 |
| 392 |
SHOCK HAEMORRHAGIC |
8 |
0.0010 |
| 393 |
PNEUMONIA BACTERIAL |
9 |
0.0010 |
| 394 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
1 |
0.0010 |
| 395 |
VARICELLA ZOSTER VIRUS INFECTION |
2 |
0.0010 |
| 396 |
TRANSFUSION |
10 |
0.0010 |
| 397 |
INTERSTITIAL LUNG DISEASE |
46 |
0.0009 |
| 398 |
NEUROGENIC BLADDER |
2 |
0.0009 |
| 399 |
AMAUROSIS FUGAX |
1 |
0.0009 |
| 400 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 401 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
3 |
0.0009 |
| 402 |
OTITIS MEDIA |
3 |
0.0009 |
| 403 |
IMMUNOSUPPRESSION |
8 |
0.0009 |
| 404 |
ILEUS PARALYTIC |
4 |
0.0009 |
| 405 |
CEREBRAL HAEMORRHAGE |
32 |
0.0009 |
| 406 |
HAEMOLYTIC ANAEMIA |
8 |
0.0009 |
| 407 |
PERICARDITIS |
15 |
0.0009 |
| 408 |
BLOOD BILIRUBIN INCREASED |
24 |
0.0009 |
| 409 |
TONGUE ULCERATION |
3 |
0.0009 |
| 410 |
PAPILLOEDEMA |
4 |
0.0009 |
| 411 |
GRANULOCYTOPENIA |
5 |
0.0009 |
| 412 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
9 |
0.0009 |
| 413 |
LUMBAR VERTEBRAL FRACTURE |
4 |
0.0009 |
| 414 |
LEFT VENTRICULAR FAILURE |
3 |
0.0009 |
| 415 |
PNEUMONIA |
282 |
0.0009 |
| 416 |
CYTOMEGALOVIRUS COLITIS |
2 |
0.0009 |
| 417 |
AGRANULOCYTOSIS |
16 |
0.0009 |
| 418 |
DRUG-INDUCED LIVER INJURY |
27 |
0.0009 |
| 419 |
BILIRUBIN CONJUGATED INCREASED |
2 |
0.0009 |
| 420 |
THROMBOPHLEBITIS |
3 |
0.0009 |
| 421 |
HAEMORRHAGE SUBCUTANEOUS |
3 |
0.0008 |
| 422 |
EMBOLISM |
7 |
0.0008 |
| 423 |
CYTOMEGALOVIRUS INFECTION |
14 |
0.0008 |
| 424 |
CARDIAC TAMPONADE |
4 |
0.0008 |
| 425 |
GASTROINTESTINAL TOXICITY |
4 |
0.0008 |
| 426 |
ASPARTATE AMINOTRANSFERASE INCREASED |
44 |
0.0008 |
| 427 |
BLAST CRISIS IN MYELOGENOUS LEUKAEMIA |
1 |
0.0008 |
| 428 |
RESPIRATORY FAILURE |
59 |
0.0008 |
| 429 |
ORGANISING PNEUMONIA |
4 |
0.0008 |
| 430 |
LEUKOENCEPHALOPATHY |
3 |
0.0008 |
| 431 |
ALANINE AMINOTRANSFERASE INCREASED |
49 |
0.0008 |
| 432 |
CHOLESTASIS |
15 |
0.0008 |
| 433 |
OESOPHAGEAL ULCER |
3 |
0.0008 |
| 434 |
BILIARY OBSTRUCTION |
1 |
0.0008 |
| 435 |
OPTIC NEURITIS |
7 |
0.0008 |
| 436 |
COVID-19 PNEUMONIA |
9 |
0.0008 |
| 437 |
FULL BLOOD COUNT ABNORMAL |
8 |
0.0008 |
| 438 |
CHOLECYSTITIS |
9 |
0.0008 |
| 439 |
CLOSTRIDIUM DIFFICILE COLITIS |
8 |
0.0008 |
| 440 |
PYREXIA |
261 |
0.0008 |
| 441 |
HEPATITIS |
19 |
0.0007 |
| 442 |
PERICARDIAL EFFUSION |
17 |
0.0007 |
| 443 |
CLOSTRIDIUM DIFFICILE INFECTION |
16 |
0.0007 |
| 444 |
ARTHRITIS BACTERIAL |
3 |
0.0007 |
| 445 |
DRUG LEVEL INCREASED |
12 |
0.0007 |
| 446 |
VITREOUS HAEMORRHAGE |
2 |
0.0007 |
| 447 |
BILIARY TRACT DISORDER |
1 |
0.0007 |
| 448 |
FUNGAL INFECTION |
24 |
0.0007 |
| 449 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 450 |
PSEUDOMONAS INFECTION |
6 |
0.0007 |
| 451 |
HEART VALVE INCOMPETENCE |
2 |
0.0007 |
| 452 |
CELLULITIS |
35 |
0.0007 |
| 453 |
ENCEPHALOPATHY |
17 |
0.0007 |
| 454 |
RENAL IMPAIRMENT |
58 |
0.0007 |
| 455 |
MUCOSAL INFLAMMATION |
18 |
0.0007 |
| 456 |
SUBARACHNOID HAEMORRHAGE |
7 |
0.0007 |
| 457 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
2 |
0.0007 |
| 458 |
SARS-COV-2 TEST POSITIVE |
9 |
0.0007 |
| 459 |
ABDOMINAL ABSCESS |
3 |
0.0007 |
| 460 |
PURPURA |
6 |
0.0007 |
| 461 |
HYPERBILIRUBINAEMIA |
7 |
0.0007 |
| 462 |
ACUTE RESPIRATORY FAILURE |
13 |
0.0007 |
| 463 |
CYTOMEGALOVIRUS VIRAEMIA |
3 |
0.0007 |
| 464 |
PLEURAL EFFUSION |
41 |
0.0007 |
| 465 |
THERAPY NON-RESPONDER |
30 |
0.0007 |
| 466 |
HEPATITIS CHOLESTATIC |
4 |
0.0007 |
| 467 |
DRUG RESISTANCE |
17 |
0.0007 |
| 468 |
VASCULAR DEVICE INFECTION |
3 |
0.0007 |
| 469 |
GINGIVAL BLEEDING |
9 |
0.0007 |
| 470 |
ACIDOSIS |
5 |
0.0007 |
| 471 |
CHEST X-RAY ABNORMAL |
2 |
0.0007 |
| 472 |
ANAEMIA |
124 |
0.0006 |
| 473 |
DEVICE RELATED INFECTION |
10 |
0.0006 |
| 474 |
PULMONARY OEDEMA |
29 |
0.0006 |
| 475 |
HAEMOLYSIS |
5 |
0.0006 |
| 476 |
CHOLANGITIS |
4 |
0.0006 |
| 477 |
HAEMOGLOBIN DECREASED |
66 |
0.0006 |
| 478 |
OESOPHAGITIS |
7 |
0.0006 |
| 479 |
STAPHYLOCOCCAL INFECTION |
21 |
0.0006 |
| 480 |
ENTERITIS |
4 |
0.0006 |
| 481 |
HYPOXIA |
22 |
0.0006 |
| 482 |
HAEMOGLOBIN ABNORMAL |
4 |
0.0006 |
| 483 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 484 |
STAPHYLOCOCCAL SEPSIS |
3 |
0.0006 |
| 485 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
5 |
0.0006 |
| 486 |
C-REACTIVE PROTEIN INCREASED |
22 |
0.0006 |
| 487 |
GASTROINTESTINAL HAEMORRHAGE |
50 |
0.0006 |
| 488 |
NEPHROTIC SYNDROME |
4 |
0.0006 |
| 489 |
OFF LABEL USE |
508 |
0.0006 |
| 490 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 491 |
PYELONEPHRITIS |
5 |
0.0006 |
| 492 |
PULMONARY HYPERTENSION |
12 |
0.0006 |
| 493 |
DERMATITIS EXFOLIATIVE GENERALISED |
2 |
0.0006 |
| 494 |
OEDEMA |
31 |
0.0006 |
| 495 |
MOUTH ULCERATION |
12 |
0.0006 |
| 496 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
10 |
0.0006 |
| 497 |
ANAL FISTULA |
3 |
0.0006 |
| 498 |
HAEMORRHAGIC DIATHESIS |
2 |
0.0006 |
| 499 |
COMPRESSION FRACTURE |
3 |
0.0006 |
| 500 |
RED BLOOD CELL COUNT DECREASED |
16 |
0.0006 |
| 501 |
CARDIOGENIC SHOCK |
8 |
0.0006 |
| 502 |
FACIAL BONES FRACTURE |
2 |
0.0006 |
| 503 |
MONOCYTE COUNT INCREASED |
2 |
0.0006 |
| 504 |
LIVER FUNCTION TEST ABNORMAL |
16 |
0.0005 |
| 505 |
VENTRICULAR ARRHYTHMIA |
2 |
0.0005 |
| 506 |
IMMUNE-MEDIATED ENTEROCOLITIS |
2 |
0.0005 |
| 507 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 508 |
CARDIOMYOPATHY |
8 |
0.0005 |
| 509 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0005 |
| 510 |
SKIN INFECTION |
6 |
0.0005 |
| 511 |
SKIN TOXICITY |
3 |
0.0005 |
| 512 |
AUTOIMMUNE THYROIDITIS |
2 |
0.0005 |
| 513 |
INTERNAL HAEMORRHAGE |
6 |
0.0005 |
| 514 |
CONJUNCTIVAL HAEMORRHAGE |
2 |
0.0005 |
| 515 |
LEUKOPENIA |
26 |
0.0005 |
| 516 |
BLOOD URIC ACID INCREASED |
3 |
0.0005 |
| 517 |
HYPOALBUMINAEMIA |
4 |
0.0005 |
| 518 |
MUSCLE RUPTURE |
2 |
0.0005 |
| 519 |
ORAL INFECTION |
2 |
0.0005 |
| 520 |
THERAPEUTIC RESPONSE DECREASED |
31 |
0.0005 |
| 521 |
BICYTOPENIA |
1 |
0.0005 |
| 522 |
HYPOMAGNESAEMIA |
7 |
0.0005 |
| 523 |
OESOPHAGEAL CANDIDIASIS |
2 |
0.0005 |
| 524 |
DISEASE PROGRESSION |
59 |
0.0005 |
| 525 |
RECURRENT CANCER |
2 |
0.0005 |
| 526 |
LIVER INJURY |
12 |
0.0005 |
| 527 |
HYPERURICAEMIA |
2 |
0.0005 |
| 528 |
HEPATIC ENZYME INCREASED |
33 |
0.0005 |
| 529 |
GASTROINTESTINAL PERFORATION |
2 |
0.0005 |
| 530 |
EPSTEIN-BARR VIRUS INFECTION |
3 |
0.0005 |
| 531 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0005 |
| 532 |
CANDIDA INFECTION |
8 |
0.0005 |
| 533 |
ESCHERICHIA URINARY TRACT INFECTION |
2 |
0.0005 |
| 534 |
IMMUNODEFICIENCY |
7 |
0.0005 |
| 535 |
ABSCESS LIMB |
2 |
0.0005 |
| 536 |
ANAEMIA MACROCYTIC |
1 |
0.0005 |
| 537 |
HAEMORRHAGE INTRACRANIAL |
7 |
0.0005 |
| 538 |
C-REACTIVE PROTEIN ABNORMAL |
3 |
0.0005 |
| 539 |
BLOOD POTASSIUM DECREASED |
14 |
0.0005 |
| 540 |
HEPATIC LESION |
2 |
0.0005 |
| 541 |
ALTERED STATE OF CONSCIOUSNESS |
10 |
0.0005 |
| 542 |
GENERAL PHYSICAL HEALTH DETERIORATION |
53 |
0.0005 |
| 543 |
DIVERTICULUM INTESTINAL |
2 |
0.0005 |
| 544 |
PULMONARY FUNCTION TEST DECREASED |
2 |
0.0005 |
| 545 |
MENINGITIS |
3 |
0.0004 |
| 546 |
LEFT VENTRICULAR DYSFUNCTION |
3 |
0.0004 |
| 547 |
ADENOCARCINOMA |
1 |
0.0004 |
| 548 |
TASTE DISORDER |
9 |
0.0004 |
| 549 |
BODY TEMPERATURE INCREASED |
9 |
0.0004 |
| 550 |
HAEMOGLOBIN INCREASED |
2 |
0.0004 |
| 551 |
BUNDLE BRANCH BLOCK RIGHT |
2 |
0.0004 |
| 552 |
BRAIN NEOPLASM |
4 |
0.0004 |
| 553 |
LYMPHOEDEMA |
3 |
0.0004 |
| 554 |
HAEMOPTYSIS |
12 |
0.0004 |
| 555 |
ROSACEA |
2 |
0.0004 |
| 556 |
DRUG INTERACTION |
68 |
0.0004 |
| 557 |
PAPULE |
3 |
0.0004 |
| 558 |
DISEASE RECURRENCE |
20 |
0.0004 |
| 559 |
SUBCUTANEOUS ABSCESS |
2 |
0.0004 |
| 560 |
NERVOUS SYSTEM DISORDER |
13 |
0.0004 |
| 561 |
BLOOD CREATININE INCREASED |
27 |
0.0004 |
| 562 |
RENAL CELL CARCINOMA |
2 |
0.0004 |
| 563 |
SENSITIVE SKIN |
3 |
0.0004 |
| 564 |
HYPOPHOSPHATAEMIA |
3 |
0.0004 |
| 565 |
HOSPICE CARE |
4 |
0.0004 |
| 566 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 567 |
INFLAMMATORY MARKER INCREASED |
2 |
0.0004 |
| 568 |
ERYSIPELAS |
2 |
0.0004 |
| 569 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 570 |
HYPOKALAEMIA |
18 |
0.0004 |
| 571 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
2 |
0.0004 |
| 572 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1 |
0.0004 |
| 573 |
THERAPY PARTIAL RESPONDER |
6 |
0.0004 |
| 574 |
PETECHIAE |
4 |
0.0004 |
| 575 |
PRODUCT USE COMPLAINT |
6 |
0.0004 |
| 576 |
ORAL CANDIDIASIS |
5 |
0.0004 |
| 577 |
PULMONARY CONGESTION |
5 |
0.0004 |
| 578 |
COVID-19 |
66 |
0.0004 |
| 579 |
ATRIAL FLUTTER |
3 |
0.0004 |
| 580 |
ANIMAL BITE |
1 |
0.0004 |
| 581 |
ANAL ABSCESS |
2 |
0.0004 |
| 582 |
RESPIRATORY DISORDER |
11 |
0.0004 |
| 583 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
9 |
0.0004 |
| 584 |
ANGIOPATHY |
2 |
0.0004 |
| 585 |
ACUTE PULMONARY OEDEMA |
2 |
0.0004 |
| 586 |
BLOOD CALCIUM DECREASED |
4 |
0.0004 |
| 587 |
STATUS EPILEPTICUS |
4 |
0.0004 |
| 588 |
PRESCRIBED UNDERDOSE |
7 |
0.0004 |
| 589 |
ANURIA |
3 |
0.0003 |
| 590 |
GASTRIC HAEMORRHAGE |
4 |
0.0003 |
| 591 |
EXERCISE TOLERANCE DECREASED |
2 |
0.0003 |
| 592 |
LUNG DISORDER |
17 |
0.0003 |
| 593 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
3 |
0.0003 |
| 594 |
ELECTROLYTE IMBALANCE |
4 |
0.0003 |
| 595 |
HYPERTRIGLYCERIDAEMIA |
2 |
0.0003 |
| 596 |
FEELING OF BODY TEMPERATURE CHANGE |
2 |
0.0003 |
| 597 |
GASTROINTESTINAL INFECTION |
3 |
0.0003 |
| 598 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 599 |
PLATELET COUNT ABNORMAL |
2 |
0.0003 |
| 600 |
CEREBRAL INFARCTION |
8 |
0.0003 |
| 601 |
UROSEPSIS |
3 |
0.0003 |
| 602 |
SKIN CANCER |
7 |
0.0003 |
| 603 |
LARYNGEAL OEDEMA |
2 |
0.0003 |
| 604 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 605 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 606 |
OLIGURIA |
2 |
0.0003 |
| 607 |
ILEUS |
4 |
0.0003 |
| 608 |
APPENDICITIS |
3 |
0.0003 |
| 609 |
ACUTE KIDNEY INJURY |
49 |
0.0003 |
| 610 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 611 |
DEATH |
273 |
0.0003 |
| 612 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
7 |
0.0003 |
| 613 |
RASH MACULO-PAPULAR |
7 |
0.0003 |
| 614 |
BILE DUCT STONE |
1 |
0.0003 |
| 615 |
CARDIAC FAILURE |
25 |
0.0003 |
| 616 |
DIZZINESS POSTURAL |
3 |
0.0003 |
| 617 |
HAEMATOMA |
8 |
0.0003 |
| 618 |
AUTOIMMUNE DISORDER |
3 |
0.0003 |
| 619 |
RESPIRATORY TRACT INFECTION |
8 |
0.0003 |
| 620 |
MALIGNANT NEOPLASM PROGRESSION |
31 |
0.0003 |
| 621 |
COAGULOPATHY |
5 |
0.0003 |
| 622 |
SKIN MASS |
2 |
0.0003 |
| 623 |
CYTOKINE RELEASE SYNDROME |
6 |
0.0003 |
| 624 |
FACE OEDEMA |
5 |
0.0003 |
| 625 |
TACHYCARDIA |
26 |
0.0003 |
| 626 |
HAEMATURIA |
10 |
0.0003 |
| 627 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 628 |
ECCHYMOSIS |
2 |
0.0003 |
| 629 |
ONYCHOCLASIS |
2 |
0.0003 |
| 630 |
COLITIS |
11 |
0.0003 |
| 631 |
VENTRICULAR EXTRASYSTOLES |
3 |
0.0003 |
| 632 |
AORTIC STENOSIS |
1 |
0.0003 |
| 633 |
SCRATCH |
3 |
0.0003 |
| 634 |
DRUG ERUPTION |
5 |
0.0003 |
| 635 |
PNEUMONIA ASPIRATION |
7 |
0.0003 |
| 636 |
BONE LESION |
1 |
0.0003 |
| 637 |
MYELODYSPLASTIC SYNDROME |
4 |
0.0003 |
| 638 |
GASTROENTERITIS |
4 |
0.0003 |
| 639 |
WOUND INFECTION |
3 |
0.0003 |
| 640 |
ASPIRATION |
3 |
0.0003 |
| 641 |
LABORATORY TEST ABNORMAL |
8 |
0.0003 |
| 642 |
PSYCHIATRIC SYMPTOM |
2 |
0.0003 |
| 643 |
BONE DENSITY ABNORMAL |
1 |
0.0003 |
| 644 |
EPISTAXIS |
20 |
0.0003 |
| 645 |
TUBULOINTERSTITIAL NEPHRITIS |
5 |
0.0003 |
| 646 |
EYE INFECTION |
3 |
0.0003 |
| 647 |
HYPERTHERMIA |
2 |
0.0003 |
| 648 |
PULMONARY FIBROSIS |
5 |
0.0003 |
| 649 |
PNEUMONITIS |
7 |
0.0003 |
| 650 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 651 |
ELECTROCARDIOGRAM ABNORMAL |
2 |
0.0003 |
| 652 |
BLEPHARITIS |
1 |
0.0002 |
| 653 |
STOMATITIS |
15 |
0.0002 |
| 654 |
NEURALGIA |
6 |
0.0002 |
| 655 |
HYPERCALCAEMIA |
3 |
0.0002 |
| 656 |
VENTRICULAR TACHYCARDIA |
4 |
0.0002 |
| 657 |
AORTIC DISSECTION |
1 |
0.0002 |
| 658 |
HAIR COLOUR CHANGES |
3 |
0.0002 |
| 659 |
HEMIPLEGIA |
2 |
0.0002 |
| 660 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
3 |
0.0002 |
| 661 |
INFLAMMATION |
12 |
0.0002 |
| 662 |
HEPATIC FAILURE |
7 |
0.0002 |
| 663 |
BLOOD MAGNESIUM DECREASED |
2 |
0.0002 |
| 664 |
HYPONATRAEMIA |
13 |
0.0002 |
| 665 |
PLATELET COUNT INCREASED |
3 |
0.0002 |
| 666 |
PRODUCT PRESCRIBING ISSUE |
5 |
0.0002 |
| 667 |
NEUROTOXICITY |
4 |
0.0002 |
| 668 |
BEDRIDDEN |
3 |
0.0002 |
| 669 |
EYE HAEMORRHAGE |
3 |
0.0002 |
| 670 |
HEART RATE IRREGULAR |
5 |
0.0002 |
| 671 |
DYSPHAGIA |
21 |
0.0002 |
| 672 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 673 |
SKIN LESION |
6 |
0.0002 |
| 674 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
12 |
0.0002 |
| 675 |
SHOCK |
5 |
0.0002 |
| 676 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 677 |
ERYTHEMA MULTIFORME |
2 |
0.0002 |
| 678 |
BLINDNESS UNILATERAL |
3 |
0.0002 |
| 679 |
SINUS TACHYCARDIA |
3 |
0.0002 |
| 680 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
15 |
0.0002 |
| 681 |
VIRAL INFECTION |
7 |
0.0002 |
| 682 |
PARALYSIS |
3 |
0.0002 |
| 683 |
CONDITION AGGRAVATED |
63 |
0.0002 |
| 684 |
LOCALISED INFECTION |
5 |
0.0002 |
| 685 |
CARDIAC ARREST |
17 |
0.0002 |
| 686 |
ORAL HERPES |
4 |
0.0002 |
| 687 |
ASCITES |
6 |
0.0002 |
| 688 |
VITREOUS FLOATERS |
2 |
0.0002 |
| 689 |
LIGAMENT SPRAIN |
2 |
0.0002 |
| 690 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 691 |
PULMONARY MASS |
3 |
0.0002 |
| 692 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 693 |
BLOOD PRESSURE ABNORMAL |
4 |
0.0002 |
| 694 |
HAEMORRHAGE |
21 |
0.0002 |
| 695 |
DRUG LEVEL DECREASED |
2 |
0.0002 |
| 696 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 697 |
HOSPITALISATION |
30 |
0.0002 |
| 698 |
TEMPERATURE INTOLERANCE |
2 |
0.0002 |
| 699 |
HERPES ZOSTER |
11 |
0.0002 |
| 700 |
DEAFNESS |
5 |
0.0002 |
| 701 |
PRODUCT USE IN UNAPPROVED INDICATION |
47 |
0.0002 |
| 702 |
DEPRESSED MOOD |
10 |
0.0002 |
| 703 |
SUDDEN DEATH |
2 |
0.0002 |
| 704 |
METABOLIC ACIDOSIS |
6 |
0.0002 |
| 705 |
RASH |
81 |
0.0002 |
| 706 |
PAIN OF SKIN |
5 |
0.0002 |
| 707 |
LACTIC ACIDOSIS |
6 |
0.0002 |
| 708 |
FAECES DISCOLOURED |
4 |
0.0002 |
| 709 |
OSTEONECROSIS |
6 |
0.0002 |
| 710 |
GAIT INABILITY |
6 |
0.0002 |
| 711 |
MALNUTRITION |
2 |
0.0002 |
| 712 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 713 |
REBOUND EFFECT |
2 |
0.0002 |
| 714 |
FLUID RETENTION |
9 |
0.0002 |
| 715 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 716 |
PRODUCT AVAILABILITY ISSUE |
4 |
0.0002 |
| 717 |
RENAL DISORDER |
8 |
0.0002 |
| 718 |
SPLENOMEGALY |
2 |
0.0002 |
| 719 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
| 720 |
LYMPHOCYTE COUNT DECREASED |
3 |
0.0002 |
| 721 |
ACUTE MYOCARDIAL INFARCTION |
5 |
0.0002 |
| 722 |
ATAXIA |
2 |
0.0002 |
| 723 |
RENAL INJURY |
5 |
0.0002 |
| 724 |
ACCIDENT |
2 |
0.0002 |
| 725 |
POLYNEUROPATHY |
2 |
0.0002 |
| 726 |
OSTEOMYELITIS |
3 |
0.0002 |
| 727 |
HYPOGLYCAEMIA |
8 |
0.0002 |
| 728 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 729 |
DYSURIA |
6 |
0.0002 |
| 730 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 731 |
EYE SWELLING |
6 |
0.0002 |
| 732 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 733 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 734 |
HYPOCALCAEMIA |
3 |
0.0002 |
| 735 |
BRAIN OEDEMA |
2 |
0.0002 |
| 736 |
HAEMORRHOIDS |
3 |
0.0002 |
| 737 |
BRADYPHRENIA |
1 |
0.0002 |
| 738 |
TOOTH INFECTION |
2 |
0.0002 |
| 739 |
PANCREATITIS |
8 |
0.0002 |
| 740 |
APPETITE DISORDER |
1 |
0.0002 |
| 741 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 742 |
FEEDING DISORDER |
3 |
0.0001 |
| 743 |
LIMB INJURY |
4 |
0.0001 |
| 744 |
DECREASED APPETITE |
34 |
0.0001 |
| 745 |
RIB FRACTURE |
3 |
0.0001 |
| 746 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 747 |
DIVERTICULITIS |
4 |
0.0001 |
| 748 |
RHABDOMYOLYSIS |
6 |
0.0001 |
| 749 |
RENAL FAILURE |
19 |
0.0001 |
| 750 |
HYPERKALAEMIA |
5 |
0.0001 |
| 751 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 752 |
SKIN REACTION |
2 |
0.0001 |
| 753 |
HYPERTENSION |
30 |
0.0001 |
| 754 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 755 |
LYMPHADENOPATHY |
5 |
0.0001 |
| 756 |
FLUID OVERLOAD |
2 |
0.0001 |
| 757 |
INTERVERTEBRAL DISC PROTRUSION |
3 |
0.0001 |
| 758 |
HYPERGLYCAEMIA |
5 |
0.0001 |
| 759 |
APATHY |
2 |
0.0001 |
| 760 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 761 |
COLON CANCER |
2 |
0.0001 |
| 762 |
ATRIAL FIBRILLATION |
13 |
0.0001 |
| 763 |
DYSPNOEA EXERTIONAL |
5 |
0.0001 |
| 764 |
INSURANCE ISSUE |
2 |
0.0001 |
| 765 |
SYNCOPE |
13 |
0.0001 |
| 766 |
HYPOTENSION |
26 |
0.0001 |
| 767 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 768 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 769 |
RASH PRURITIC |
7 |
0.0001 |
| 770 |
URINARY TRACT INFECTION |
22 |
0.0001 |
| 771 |
PNEUMOTHORAX |
2 |
0.0001 |
| 772 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 773 |
PRODUCT PRESCRIBING ERROR |
3 |
0.0001 |
| 774 |
DIARRHOEA |
81 |
0.0001 |
| 775 |
ABSCESS |
2 |
0.0001 |
| 776 |
HIP FRACTURE |
4 |
0.0001 |
| 777 |
MYALGIA |
21 |
0.0001 |
| 778 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 779 |
ASPHYXIA |
1 |
0.0001 |
| 780 |
SEIZURE |
14 |
0.0001 |
| 781 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 782 |
SKIN DISORDER |
4 |
0.0001 |
| 783 |
URINARY RETENTION |
4 |
0.0001 |
| 784 |
TYPE 2 DIABETES MELLITUS |
4 |
0.0001 |
| 785 |
GASTRIC CANCER |
3 |
0.0001 |
| 786 |
ASTHENIA |
44 |
0.0001 |
| 787 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 788 |
DELIRIUM |
4 |
0.0001 |
| 789 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 790 |
OEDEMA PERIPHERAL |
14 |
0.0001 |
| 791 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 792 |
DRUG INEFFECTIVE |
151 |
0.0001 |
| 793 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 794 |
BRADYCARDIA |
6 |
0.0001 |
| 795 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 796 |
JAUNDICE |
3 |
0.0001 |
| 797 |
TOOTHACHE |
2 |
0.0001 |
| 798 |
CONSTIPATION |
24 |
0.0001 |
| 799 |
HAEMATOCHEZIA |
6 |
0.0001 |
| 800 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 801 |
BLOOD GLUCOSE ABNORMAL |
2 |
0.0001 |
| 802 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 803 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 804 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 805 |
INFLUENZA |
12 |
0.0001 |
| 806 |
SINUSITIS |
11 |
0.0001 |
| 807 |
INTESTINAL OBSTRUCTION |
4 |
0.0001 |
| 808 |
UNEVALUABLE EVENT |
8 |
0.0001 |
| 809 |
FRACTURE |
2 |
0.0001 |
| 810 |
MUSCULAR WEAKNESS |
12 |
0.0001 |
| 811 |
ARRHYTHMIA |
5 |
0.0001 |
| 812 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 813 |
BLOOD PRESSURE DECREASED |
7 |
0.0001 |
| 814 |
PROTEINURIA |
2 |
0.0001 |
| 815 |
NEUROPATHY PERIPHERAL |
10 |
0.0001 |
| 816 |
INCREASED APPETITE |
2 |
0.0001 |
| 817 |
DRUG INTOLERANCE |
10 |
0.0001 |
| 818 |
CATARACT |
6 |
0.0001 |
| 819 |
BRAIN INJURY |
1 |
0.0001 |
| 820 |
EPILEPSY |
3 |
0.0001 |
| 821 |
EMOTIONAL DISORDER |
3 |
0.0001 |
| 822 |
TREATMENT FAILURE |
8 |
0.0001 |
| 823 |
CARDIAC DISORDER |
9 |
0.0001 |
| 824 |
MUSCULOSKELETAL PAIN |
5 |
0.0001 |
| 825 |
HEAD INJURY |
3 |
0.0001 |
| 826 |
CYSTITIS |
3 |
0.0001 |
| 827 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 828 |
RETCHING |
2 |
0.0001 |
| 829 |
HYPOAESTHESIA |
14 |
0.0001 |
| 830 |
DEEP VEIN THROMBOSIS |
6 |
0.0001 |
| 831 |
NAUSEA |
73 |
0.0001 |
| 832 |
DIZZINESS |
46 |
0.0001 |
| 833 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 834 |
IMPAIRED HEALING |
3 |
0.0001 |
| 835 |
NEOPLASM MALIGNANT |
6 |
0.0001 |
| 836 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 837 |
TOXICITY TO VARIOUS AGENTS |
15 |
0.0001 |
| 838 |
CHROMATURIA |
2 |
0.0001 |
| 839 |
ILLNESS |
9 |
0.0001 |
| 840 |
FALL |
29 |
0.0001 |
| 841 |
THROMBOSIS |
7 |
0.0001 |
| 842 |
DRY MOUTH |
7 |
0.0001 |
| 843 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
2 |
0.0001 |
| 844 |
COUGH |
24 |
0.0001 |
| 845 |
BONE PAIN |
5 |
0.0001 |
| 846 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 847 |
MOBILITY DECREASED |
6 |
0.0001 |
| 848 |
HEPATIC CANCER |
2 |
0.0001 |
| 849 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 850 |
FATIGUE |
63 |
0.0001 |
| 851 |
CONFUSIONAL STATE |
13 |
0.0001 |
| 852 |
WEIGHT INCREASED |
18 |
0.0001 |
| 853 |
DYSARTHRIA |
3 |
0.0001 |
| 854 |
HAEMATEMESIS |
2 |
0.0001 |
| 855 |
HYPOPHAGIA |
2 |
0.0001 |
| 856 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 857 |
SKIN ULCER |
2 |
0.0001 |
| 858 |
SWELLING FACE |
5 |
0.0001 |
| 859 |
SPEECH DISORDER |
4 |
0.0001 |
| 860 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 861 |
OROPHARYNGEAL PAIN |
7 |
0.0001 |
| 862 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 863 |
MOOD ALTERED |
2 |
0.0001 |
| 864 |
CONTUSION |
7 |
0.0001 |
| 865 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 866 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 867 |
DYSPNOEA |
40 |
0.0001 |
| 868 |
LOSS OF CONSCIOUSNESS |
9 |
0.0001 |
| 869 |
VOMITING |
33 |
0.0001 |
| 870 |
CHEST PAIN |
13 |
0.0001 |
| 871 |
SKIN BURNING SENSATION |
5 |
0.0001 |
| 872 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
14 |
0.0001 |
| 873 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 874 |
CHILLS |
8 |
0.0001 |
| 875 |
ERYTHEMA |
14 |
0.0001 |
| 876 |
BRONCHITIS |
5 |
0.0001 |
| 877 |
DYSGEUSIA |
5 |
0.0001 |
| 878 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 879 |
MALAISE |
29 |
0.0001 |
| 880 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 881 |
ILL-DEFINED DISORDER |
4 |
0.0001 |
| 882 |
VISION BLURRED |
9 |
0.0001 |
| 883 |
MEMORY IMPAIRMENT |
9 |
0.0001 |
| 884 |
SOMNOLENCE |
13 |
0.0001 |
| 885 |
VISUAL IMPAIRMENT |
8 |
0.0001 |
| 886 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 887 |
SWELLING |
6 |
0.0001 |
| 888 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 889 |
BRAIN FOG |
1 |
0.0001 |
| 890 |
PULMONARY EMBOLISM |
6 |
0.0001 |
| 891 |
MOOD SWINGS |
2 |
0.0001 |
| 892 |
NIGHT SWEATS |
2 |
0.0001 |
| 893 |
CHOLELITHIASIS |
2 |
0.0001 |
| 894 |
EYE DISORDER |
2 |
0.0001 |
| 895 |
ABDOMINAL PAIN |
14 |
0.0001 |
| 896 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 897 |
ABDOMINAL DISCOMFORT |
10 |
0.0001 |
| 898 |
ANGER |
2 |
0.0001 |
| 899 |
BLOOD PRESSURE INCREASED |
9 |
0.0001 |
| 900 |
GASTRIC DISORDER |
2 |
0.0001 |
| 901 |
PARAESTHESIA |
9 |
0.0001 |
| 902 |
PRODUCT STORAGE ERROR |
5 |
0.0001 |
| 903 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 904 |
CRYING |
2 |
0.0001 |
| 905 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 906 |
RESTLESSNESS |
2 |
0.0001 |
| 907 |
PRURITUS |
21 |
0.0001 |
| 908 |
TREMOR |
9 |
0.0001 |
| 909 |
ARTHRALGIA |
22 |
0.0001 |
| 910 |
DEHYDRATION |
7 |
0.0001 |
| 911 |
LETHARGY |
3 |
0.0001 |
| 912 |
PERIPHERAL SWELLING |
8 |
0.0001 |
| 913 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 914 |
ARTHRITIS |
4 |
0.0001 |
| 915 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 916 |
DISORIENTATION |
2 |
0.0001 |
| 917 |
HEART RATE INCREASED |
5 |
0.0001 |
| 918 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 919 |
VERTIGO |
3 |
0.0000 |
| 920 |
BLINDNESS |
2 |
0.0000 |
| 921 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 922 |
OSTEOPOROSIS |
2 |
0.0000 |
| 923 |
HYPERSENSITIVITY |
9 |
0.0000 |
| 924 |
POLLAKIURIA |
2 |
0.0000 |
| 925 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 926 |
PAIN IN EXTREMITY |
14 |
0.0000 |
| 927 |
INTENTIONAL OVERDOSE |
3 |
0.0000 |
| 928 |
BALANCE DISORDER |
4 |
0.0000 |
| 929 |
VAGINAL HAEMORRHAGE |
2 |
0.0000 |
| 930 |
MENTAL DISORDER |
2 |
0.0000 |
| 931 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 932 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 933 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 934 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
8 |
0.0000 |
| 935 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 936 |
PAIN |
27 |
0.0000 |
| 937 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 938 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 939 |
COMA |
2 |
0.0000 |
| 940 |
MIGRAINE |
4 |
0.0000 |
| 941 |
GAIT DISTURBANCE |
8 |
0.0000 |
| 942 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 943 |
PRODUCT DOSE OMISSION ISSUE |
12 |
0.0000 |
| 944 |
AGEUSIA |
1 |
0.0000 |
| 945 |
DRY EYE |
2 |
0.0000 |
| 946 |
HOT FLUSH |
3 |
0.0000 |
| 947 |
DIABETES MELLITUS |
3 |
0.0000 |
| 948 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 949 |
HEADACHE |
24 |
0.0000 |
| 950 |
ECZEMA |
2 |
0.0000 |
| 951 |
NASOPHARYNGITIS |
7 |
0.0000 |
| 952 |
INSOMNIA |
10 |
0.0000 |
| 953 |
BLISTER |
2 |
0.0000 |
| 954 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 955 |
EYE PAIN |
2 |
0.0000 |
| 956 |
CEREBROVASCULAR ACCIDENT |
6 |
0.0000 |
| 957 |
BACK PAIN |
8 |
0.0000 |
| 958 |
MYOCARDIAL INFARCTION |
6 |
0.0000 |
| 959 |
NASAL CONGESTION |
2 |
0.0000 |
| 960 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 961 |
FEELING HOT |
2 |
0.0000 |
| 962 |
OVERDOSE |
7 |
0.0000 |
| 963 |
WEIGHT DECREASED |
9 |
0.0000 |
| 964 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 965 |
HYPERHIDROSIS |
4 |
0.0000 |
| 966 |
RHINORRHOEA |
2 |
0.0000 |
| 967 |
ALOPECIA |
6 |
0.0000 |
| 968 |
DRY SKIN |
4 |
0.0000 |
| 969 |
FEELING ABNORMAL |
7 |
0.0000 |
| 970 |
BURNING SENSATION |
2 |
0.0000 |
| 971 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 972 |
HALLUCINATION |
2 |
0.0000 |
| 973 |
PALPITATIONS |
3 |
0.0000 |
| 974 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 975 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 976 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 977 |
ANXIETY |
6 |
0.0000 |
| 978 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 979 |
DYSPEPSIA |
2 |
0.0000 |
| 980 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 981 |
ARTHROPATHY |
1 |
0.0000 |
| 982 |
URTICARIA |
3 |
0.0000 |
| 983 |
ASTHMA |
2 |
0.0000 |
| 984 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 985 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 986 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 987 |
AMNESIA |
1 |
0.0000 |
| 988 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 989 |
ACNE |
1 |
0.0000 |
| 990 |
MUSCLE SPASMS |
2 |
0.0000 |
| 991 |
ADVERSE EVENT |
1 |
0.0000 |
| 992 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 993 |
DEPRESSION |
2 |
0.0000 |